Suven Pharmaceuticals Ltd. - Research Center
543064 SUVENPHAR Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 20 | Mar' 20 | Dec' 19 | Sep' 19 | Mar' 19 | |
|---|---|---|---|---|---|
| Sales | 237.39 | 184.76 | 178.71 | 272.93 | 250.92 |
| Operating profit | 98.49 | 77.36 | 79.66 | 125.49 | 122.01 |
| Interest | 3.26 | 7.20 | 7.18 | 3.99 | 1.74 |
| Gross profit | 95.59 | 75.49 | 77.37 | 126.94 | 120.68 |
| EPS (Rs) | 5.13 | 4.18 | 4.09 | 7.06 | 5.88 |
Quarterly
results in details
| Sep' 20 | Mar' 20 | Dec' 19 | Sep' 19 | Mar' 19 | |
|---|---|---|---|---|---|
| Other income | 0.36 | 5.34 | 4.89 | 5.45 | 0.41 |
| Stock adjustment | -3.56 | -11.27 | -13.04 | 30.58 | 13.02 |
| Raw material | 77.18 | 64.24 | 56.86 | 60.48 | 62.35 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 20.93 | 19.52 | 17.57 | 15.26 | 16.28 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | 3.81 | - | - | 5.29 | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 40.53 | 34.92 | 37.66 | 35.84 | 37.26 |
| Provisions made | - | - | - | - | - |
| Depreciation | 7.50 | 7.05 | 5.60 | 5.53 | 5.96 |
| Taxation | 22.76 | 15.20 | 19.77 | 31.49 | 39.90 |
| Net profit / loss | 65.33 | 53.24 | 52.00 | 89.92 | 74.82 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 12.73 | 12.73 | 12.73 | 12.73 | 12.73 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 41.49 | 41.87 | 44.58 | 45.98 | 48.63 |
| GPM (%) | 40.21 | 39.71 | 42.14 | 45.60 | 48.02 |
| NPM (%) | 27.48 | 28.01 | 28.32 | 32.30 | 29.77 |
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis